Status:
UNKNOWN
Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study
Lead Sponsor:
All India Institute of Medical Sciences
Conditions:
Ovarian Carcinoma
Eligibility:
FEMALE
20-65 years
Phase:
PHASE3
Brief Summary
To determine the impact of Neoadjuvant chemotherapy on surgical debulking rate, overall and disease-free survival and quality of life (QOL) in patients with advanced EOC.
Eligibility Criteria
Inclusion
- Age:20 to 65 years
- Epithelial ovarian carcinoma
- Stage IIIc \& IV (pleural effusion only)
- ECOG PS 0-2
- Cytology/biopsy positive patients
- Good compliance
- Previously untreated patients
Exclusion
- Any medical contraindication of surgery
- Psychiatric illness
- Cardiac, liver or renal dysfunction
Key Trial Info
Start Date :
November 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2009
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00715286
Start Date
November 1 2001
End Date
June 1 2009
Last Update
July 15 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, India, 110029